Trials / Conditions / Lung Adenocarcinoma Stage III
Lung Adenocarcinoma Stage III
3 registered clinical trials studyying Lung Adenocarcinoma Stage III — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors NCT07161713 | Barbara Nemesure | N/A |
| Recruiting | Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resecta NCT05503667 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |
| Completed | Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma NCT04201756 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |